CoChat

Determinants of preeclampsia in women with type 1 diabetes

Open access
Gutaj, Paweł, Zawiejska, Agnieszka, Mantaj, Urszula, Wender-Ożegowska, Ewa · 2017 · Acta Diabetologica
Cited by 39

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Despite improvement in diabetic care over the years, the incidence of hypertensive disorders of pregnancy is still very high. Therefore, the aim of our study was to determine risk factors for PE in women with T1DM. This study was a prospective, nested case–control study on a population of 165 women with T1DM. Women were divided into 3 subgroups: normotensive ( N = 141), gestational hypertension (GH) ( N = 8), and PE ( N = 16). Clinical data were collected in the first trimester (< 12th week), in mid-pregnancy (20–24th weeks), and just prior to delivery (34–39th weeks). IR in the first trimester was quantified using the estimated glucose disposal rate formula (eGDR, milligrams/kilogram/minute). Simple logistic regression was used to search for factors associated with PE and GH. For multivariate comparisons, we used multiple logistic regression with stepwise selection. All preeclampsia cases were diagnosed in primiparae. The presence of vasculopathy was the strongest determinant of PE (OR 10.8, 95% CI 3.27–35.97, P = 0.0001), followed by a history of chronic hypertension (6.05, 1.75–20.8, P = 0.004) and the duration of diabetes (1.11, 1.03–1.12, P = 0.009). However, chronic hypertension and duration of diabetes were no longer associated with PE after adjustment for the presence of vasculopathy. Higher gestational weight gain (GWG) was associated with PE, and this association remained significant after adjustment for first trimester body mass index (1.14, 1.02–1.28, P = 0.02). Both systolic and diastolic blood pressure assessed in the first trimester were significant determinants of PE; however, this association was no longer observed after adjustment for the presence of chronic hypertension. Glycated hemoglobin (HbA 1c ) levels from all 3 trimesters were significantly associated with PE (first trimester: 1.38, 1.01–1.87, P = 0.04; second trimester: 2.76, 1.43–5.31, P = 0.002; third trimester: 2.42, 1.30–4.51, P = 0.005). There was a negative association between eGDR and PE (0.66, 0.50–0.87, P = 0.003). Among lipids, triglycerides (TG) in all 3 trimesters were positively associated with PE, and this association was independent of HbA 1c levels (first trimester: 5.32, 1.65–17.18, P = 0.005; second trimester: 2.52, 1.02–6.26, P = 0.05; third trimester: 2.28, 1.39–3.74, P = 0.001. We did not find any predictors of GH in the regression analysis among all analyzed factors. Primiparity and diabetic vasculopathy seem to be the strongest risk factors for PE in women with type 1 diabetes. However, preexisting hypertension and higher GWG were also associated with PE in women with T1DM. Among laboratory results, higher HbA 1c and TG levels in all 3 trimesters were associated with PE. The association between higher IR and PE in women with T1DM needs further study.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00592-017-1053-3

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 39

Metadata

Authors
Gutaj, P., Zawiejska, A., Mantaj, U., & Wender-Ożegowska, E.
Venue
Acta Diabetologica
Published
2017-10-03
Volume
54
Issue
12
Pages
1115-1121
ISSN
  • 0940-5429 (ISSN-L)
  • 1432-5233
OpenAlex
W2763419546
Cited by
39
References
6
FWCI
3.33
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.